DI
DataBiologics, Inc.
SEC filingOther Health Care · Mesa, AZ
Amount raised$815Ksold at filing
Total offering$2M$1.2M still open
Investors in the raise16count reported to the SEC
FiledSep 24, 2025first sale Feb 16, 2022
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Luke MalangaExecutive Officer, Director
Leah BraddellExecutive Officer, Director
Jay BowenExecutive Officer, Director
Christopher RogersExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.